To access this element change to forms mode OFF
Grant Award View - GA279537
Molecular mechanisms underlying NF1 dysfunction in tumour growth and...
GA ID:
GA279537
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$955,357.10
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Molecular mechanisms underlying NF1 dysfunction in tumour growth and disease
Purpose:
Mutations of the neurofibromin tumour suppressor gene cause the common genetic disease neurofibromatosis type 1 and drive numerous cancers including melanoma, breast and brain cancer. We will apply new breakthrough technologies to uncover how the neurofibromin protein is dysregulated at the atomic level and inside the cell. This project will discover new pathways for therapeutic intervention for Australians living with NF1-linked disease.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2020646
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA